sulfasalazine has been researched along with Hereditary Autoinflammation Diseases in 3 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yang, X | 1 |
Wu, D | 1 |
Li, J | 1 |
Shen, M | 1 |
Zhang, W | 1 |
Estephan, M | 1 |
Yao, Q | 2 |
Springer, J | 1 |
Shen, B | 1 |
1 review available for sulfasalazine and Hereditary Autoinflammation Diseases
Article | Year |
---|---|
A Chinese case series of Yao syndrome and literature review.
Topics: Adult; Asian People; China; Female; Fever; Foot; Genetic Variation; Genotype; Glucocorticoids; Hered | 2018 |
2 other studies available for sulfasalazine and Hereditary Autoinflammation Diseases
Article | Year |
---|---|
Case of NOD2-Associated Autoinflammatory Disease Successfully Treated With Sulfasalazine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Hereditary Autoinflammatory Diseases; Humans; Male; Nod2 Si | 2017 |
A Systematic Analysis of Treatment and Outcomes of NOD2-Associated Autoinflammatory Disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Huma | 2017 |